A CloudMD Company
x
Sign in Get iMD Health

Introducing iMD’s New Partner The Melanoma Network of Canada!

Melanoma Network of Canada and CloudMD’s iMD Health Global announce partnership to provide credible health resources into the hands of care providers and their patients across Canada.


December 17, 2020 – Oakville, Ontario

The Melanoma Network of Canada (MNC) is pleased to announce an important partnership with iMD Health Global (iMD) – a software company focused on health education – to provide their credible melanoma resources, within the iMD platform, providing greater access to thousands of healthcare providers and their millions of patients.

“iMD’s innovative platform allows health professionals to access thousands of educational images, videos and resources,” said Falyn Katz, MNC’s vice-president. “We’re excited that the valuable resources we’ve created at the MNC will now be available through iMD, improving communication and understanding between patients and care providers at  the point of care, yielding a more informed and increased engagement of melanoma patients across Canada.”

iMD Health is the largest health educational platform in Canada.  iMD offers innovative technology that facilitates meaningful dialogue between healthcare professionals and patients inside the examination room, hospital bedsides and the during pharmacy consultations.  iMD’s award winning platform enables healthcare professionals to instantly access thousands of educational graphics, videos and resources at the point of care, across Canada.

The Melanoma Network of Canada’s highly-engaging patient resources will now be counted among the many available options to support family healthcare professionals and dermatology specialists alike engage and inform their patients across a wide variety of topics such as melanomasun damage, and skin cancer.

For a full listing of Melanoma Network Canada content, click here.

“In Canada, melanoma has more than tripled in the past 30 years. An alarming trend considering some basic lifestyle changes – such as sun safety practices and an understanding of the dangers of tanning beds – can go a long way to prevention,” said Jared Sonnenberg, iMD’s Vice President of User Engagement, “This is where our partnership with MNC exploits a natural synergy; allowing trusted and valued patient education information to find its way into the hands of physicians and their patients when and where they need it most.”

As of today, healthcare professional users of the iMD platform are now able to share with their patients the many factsheets, tips and tricks brochures, and instructional videos developed by MNC. Patients will then be able to make more informed and responsible decisions, which is at the heart of a prevention-oriented, patient-centred approach.

About Melanoma Network of Canada

The Melanoma Network of Canada (MNC) is the country’s leading voice for melanoma and skin cancer patients, promoting early detection and improved treatment access and providing critical cancer support programs and information. In addition, MNC works diligently to prevent more Canadians from developing melanoma and skin cancer through public awareness initiatives and educating youth and adults alike on the importance of sun safety. 

For more information, contact Mary Zawadski, Patient Care Specialist.   mzawadski@melanomanetwork.ca

About iMD Health Global

iMD Health Global is a Toronto-based eHealth software development company, focused on innovating healthcare education.  Since 2010, iMD has grown into Canada’s largest digital patient engagement platform. Centred “At The Point of Care”®, healthcare professionals use iMD’s cloud-based platform (in clinic or virtual consults) to engage with their patients at a deeper level and optimize knowledge transfer surrounding a patient’s condition and treatment plan. This is done through the seamless integration of over 80,000 images, booklets, and video resources, (covering 2,100 medical topics) into an award-winning user interface that makes patient education both efficient and effective. At the end of a patient’s consult, a summary of all the discussed information can be emailed to the patient to review and continue their learning journey at home, improving their health literacy and adherence to their treatment plan. The iMD platform is utilized by over 10,000 clinicians (doctor’s, nurses and pharmacists in, clinics, hospitals, pharmacies, infusion clinics and in homecare settings.  For more information please visit: www.imdhealth.com and app.imdhealth.com. iMD Health is a subsidiary of CloudMD Software & Services (TSXV: DOC)

For more information, contact Jared Sonnenberg, VP   jared.sonnenberg@imdhealth.com

About CloudMD Software & Services

CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) is a telehealth company revolutionizing the delivery of healthcare to patients. CloudMD is digitizing the delivery of healthcare by providing a patient centric approach, with an emphasis on continuity of care. The Company offers SAAS based health technology solutions to healthcare providers across North America and has developed proprietary technology that delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, educational resources and artificial intelligence (AI). CloudMD currently services a combined ecosystem of over 500 clinics, almost 4000 licensed practitioners and 8 million patient charts across North America. www.cloudmd.ca  

For more information, contact Julia Becker, VP Investor Relations   julia@cloudmd.ca